Bladder Cancer Trial, Recruiting NCT05558111 Sponsor: Zhujiang Hospital Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT05558111
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are right-handed
  • People who are at least 3 months past their surgery
  • People who have no medical reasons preventing them from having an fMRI scan
  • People who are willing to sign a consent form agreeing to take part

Who may not be able to join:

  • People who have had radiotherapy to the bladder
  • People who have a history of prostate cancer
  • People who have a condition that affects pressure in the abdomen
  • People who have a history of abnormal brain structure, brain surgery, brain tumours, or radiotherapy to the brain
  • People who have a history of mental health disorders, Parkinson's disease, Alzheimer's disease, epilepsy, stroke, or bleeding in the brain
  • People who experience severe anxiety in enclosed spaces (claustrophobia) or who have metal implants in their body that are not safe for MRI scanning
  • People who have a condition affecting how the lower urinary tract (bladder and urethra) works, such as a spinal cord injury or nerve damage related to diabetes
  • People who have a narrowing of the urethra (the tube that carries urine out of the body)
  • People who are unwilling to sign the required consent form
  • People who the trial investigator considers unsuitable for other reasons (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chunxiao Liu, Southern Medical University, China

Phone: 13302296795

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zhujiang Hospital
Registry
ClinicalTrials.gov
Start date
1 June 2022
Est. completion
1 January 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The location of brain functional activation areas; The peak T-value size of the activation region

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov